SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Lyell Immunopharma Inc. (LYEL) on Thursday reported a loss of $140.7 million in its fourth quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of $7.68.
The biotechnology firm posted revenue of $6,000 in the period.
For the year, the company reported a loss of $274.4 million, or $16.06 per share. Revenue was reported as $36,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LYEL at https://www.zacks.com/ap/LYEL
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
